Loma Linda, California 92354


Purpose:

The study will measure the effects of eye exams on markers of stress in the urine. In addition, measurements will be taken to show the effects of stress on brain activity, O2 sats, and blood flow.


Criteria:

Inclusion Criteria: - Premature infants between 24 -32 weeks of gestational age Exclusion Criteria: - Infants scheduled for laser eye surgery on the day of the examination - Infants with intraventricular hemorrhage ≥ grade 3 (Papile classification) diagnosed by head ultrasound - Infants receiving the following medications: morphine, fentanyl, methadone, midazolam, lorazepam, muscle relaxants, phenobarbital, phenytoin, levetiracetam - Renal injury defined with plasma creatinine > 1.5 mg/dL - Severe cyanotic congenital heart disease - Unstable respiratory distress (hypoxemia PaO2 < 50 mm Hg or SpO2 < 90%)


NCT ID:

NCT02415205


Primary Contact:

Principal Investigator
Andrew Hopper, MD
Loma Linda University

Andrew Hopper, MD
Phone: (909) 558-7448


Backup Contact:

Danilyn Angeles, PhD
Phone: 909-558-7563


Location Contact:

Loma Linda, California 92354
United States

Danilyn M Angeles, PhD
Phone: 909-558-7563
Email: dangeles@llu.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.